Cellectar to present at bio ceo & investor digital conference

Florham park, n.j., feb. 10, 2021 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that james caruso, president and ceo will present a company overview at the virtual 2021 bio ceo & investor digital conference to be held from february 16-18, 2021.
CLRB Ratings Summary
CLRB Quant Ranking